What's in Nanjing Zenshine Pharmaceuticals's pipeline?

Nanjing Zenshine Pharmaceuticals has 5 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 4 in Phase 1.

Which companies overlap with Nanjing Zenshine Pharmaceuticals's portfolio?

Top competitors by shared drug class: Boryung Pharmaceutical Co., Ltd, Fujian Akeylink Biotechnology Co., Ltd., PMG Pharm Co., Ltd, Qilu Pharmaceutical Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nanjing-zenshine-pharmaceuticals.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Nanjing Zenshine Pharmaceuticals — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nanjing Zenshine Pharmaceuticals pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ZX-7101A for oral suspension	ZX-7101A for oral suspension	phase 3	HIF-1α inhibitor	HIF-1α	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Boryung Pharmaceutical Co., Ltd · 1 shared drug class
Fujian Akeylink Biotechnology Co., Ltd. · 1 shared drug class
PMG Pharm Co., Ltd · 1 shared drug class
Qilu Pharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nanjing Zenshine Pharmaceuticals:

Cite this brief

Drug Landscape (2026). Nanjing Zenshine Pharmaceuticals — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nanjing-zenshine-pharmaceuticals. Accessed 2026-05-18.